Sartorius and LFB Biomanufacturing expand their CDMO partnership, integrating engineered CHO cell lines with GMP manufacturing capabilities.

AGC Biologics and Pyramid Pharma Services partner to offer integrated drug development and fill-finish services for US-based biopharmaceutical clients.

Pierre-Alain Ruffieux of Cytiva discusses key biotech trends including new modalities, AI adoption, supply chain stability, ...

BioPhorum's technology maturity matrix maps the journey from manual operations to fully autonomous, lights-out ...

VectorBuilder made an agreement with MaxCyte, a biotechnology and electroporation company. The partnership will focus on ...

KBI CSO Sigma Mostafa speaks with BioProcess International's Chris Spivey about the company's 30 years of partnering with ...

Shilpa Biologicals commissions ADC GMP plant in India, offering end-to-end drug substance manufacturing to meet FDA and EMA ...

CDMO Resilience relocates HQ to Blue Ash, Ohio, from San Diego, expanding sterile injectable manufacturing and adding 200 ...

USP reports drug shortages dropped to 71 in 2025 but now last over 5 years on average, driven by low pricing, supply chain ...

Quality by design is critical for cell and gene therapy manufacturing where process controls directly influence product ...

Streamline cell line transfer with flexible process design, data-driven strategies, and real-world insights to reduce risk ...

Explore the latest news and expert commentary by Jon Kruger, brought to you by the Contributor of BioProcess International.